So if I’m interpreting this correctly … even when they’re initially giving away the BlastX free for the trial phase, the margin on the Collagen makes the combined sale to Medicare profitable? Is that how others read this?
- Forums
- ASX - By Stock
- Ann: Next Science US Medicare accreditation signals growth
So if I’m interpreting this correctly … even when they’re...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NXS (ASX) to my watchlist
|
|||||
Last
25.5¢ |
Change
-0.010(3.77%) |
Mkt cap ! $74.50M |
Open | High | Low | Value | Volume |
26.0¢ | 26.0¢ | 24.0¢ | $110.4K | 441.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9000 | 25.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.0¢ | 30097 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 36164 | 0.250 |
1 | 4255 | 0.235 |
4 | 35752 | 0.220 |
1 | 25000 | 0.215 |
1 | 4692 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.260 | 30097 | 1 |
0.265 | 50000 | 1 |
0.270 | 70961 | 3 |
0.290 | 606 | 1 |
0.295 | 3390 | 1 |
Last trade - 16.10pm 21/08/2024 (20 minute delay) ? |
Featured News
NXS (ASX) Chart |